http://rdf.ncbi.nlm.nih.gov/pubchem/patent/NZ-513328-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_74c0cf86fd85cd2f83fb8568d3834924
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-352
filingDate 2000-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_83bf30aca4cc12293e55d3162a190b0f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4f04b8370f9231290e33b377c52ed5b
publicationDate 2004-01-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber NZ-513328-A
titleOfInvention Cardiovascular and bone treatment composition comprising formononetin and one or more other isoflavone
abstract A composition comprises formononetin and one or more isoflavones selected from biochanin, genistein and daidzen, in a ratio of formononetin to isoflavone of 15:1 to 2:1 optionally in association with one or more carriers, excipients, auxiliaries and/or diluents. The composition is useful in the prevention and/or treatment of cardiovascular diseases, the beneficial alteration of blood lipoprotein levels, to reduce the risk of coronary heart disease, to reduce the risk of arteriosclerosis, in the beneficial alteration or maintenance of bone density, and in the prevention and/or treatment of osteoporosis and bone factures. Preferably the formononetin and biochanin comprise an extract of chickpea or clover.
priorityDate 1999-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID3827
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72304
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419587073
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529030
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280373
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280378
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID3827
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490899
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529050
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419529019
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281377

Total number of triples: 37.